New Mexico Cannabis Business Guide

Recreational

New Mexico launched recreational sales in 2022 with consumption lounges permitted, making it a unique market for cannabis tourism.

Active Licenses

500

Regulator

Regulation and Licensing Department (RLD)

Testing Labs

3

Consumption Lounges

Legal

Testing Labs in New Mexico

View all

Cannabis Professionals Serving New Mexico

View all

Latest Updates

All news
FederalMar 30, 2026

Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline

Congressman Steve Cohen sent a letter to AG Bondi and DEA Administrator Cole demanding an update on cannabis rescheduling progress. The letter came 99 days after Trump signed the executive order directing 'expeditious' completion of Schedule III rulemaking.

FederalMar 18, 2026

New Congressional Research Report on Cannabis Rescheduling Published

Congressional researchers released a new analysis noting that rescheduling would be a 'transitional' step requiring follow-up banking, commerce, and justice reforms. The report emphasized that rescheduling alone would not bring state markets into compliance with federal law.

LicensingMar 16, 2026

Virginia Legislature Sends Cannabis Sales Legalization Bill to Governor

Virginia's legislature voted to adopt legislation legalizing adult-use cannabis dispensary sales, sending the bill to Gov. Spanberger's desk. The bill sets a January 1, 2027 launch date for retail sales, covering taxes, licensing, and regulatory duties.

Tax & FinanceMar 12, 2026

Cannabis MSOs Owe $1.6 Billion in Unpaid 280E Taxes as IRS Fights Back

Major cannabis multistate operators collectively owe more than $1.6 billion in unpaid federal taxes under Section 280E. The IRS argued that Trump's rescheduling executive order does not change tax obligations because it has not been finalized.

Tax & FinanceMar 12, 2026

IRS Disputes Cannabis Company's Challenge to 280E in Tax Court

The IRS filed arguments in Tax Court against New Mexico cannabis company Ultra Health, which challenged the applicability of Section 280E. The IRS called Ultra Health's argument for the court to conduct its own rescheduling review an 'imaginary process.'